Back to "The Group"
 		Donna Groom began singing at 18 months and learned to play the piano at 2 and a half. She also learned to play the pipe organ and played regularly for service at 9 years old. Her formal training was with concert pianists in Dayton Ohio and Pittsburgh Pennsylvania. These studies took her through many years of performances and competitions, some of which she was a first place winner. One of her accomplishments was performing the Grieg Piano Concerto with the symphony orchestra at 15.

After attending Duquesne University on scholarship, she joined "Jimmy Beaumont and The Skyliners" as the female lead vocalist. The Pittsburgh based group is best known for their 1959 hit single, "Since I Don't Have You". Their performances have taken them all over the country in most major music halls including Radio City and Madison Square Gardens in New York City, Symphony Hall in Boston, Academy of Music in Philadelphia, Westbury Music Fair in Long Island, and The Greek Theater in Los Angeles.

Donna and Skyliners' drummer Mark Groom currently work as a self-contained act that has been playing better nightspots across the country. In an age of computer generated music, Donna and Mark play everything live. Donna plays all keyboards and bass pedals.

Ms. Groom is also a professional studio musician and singer. She has written and recorded many TV and radio jingles, both local and regional. She has a CD in Japan titled "Mind Cruisin'", and was a featured guest artist on several others.

Donna graduated cum laud from Duquesne University in May of 2004, with a degree in organ and sacred music. She serves as the Minister of Music at Christ the Divine Teacher Parish and is a member of the American Guild of Organists (AGO) where she holds the Colleague certificate, and a position on the executive board. She is also a member of the National Association of Pastoral Musicians (NPM), and the American Federation of Television and Radio Artists (AFTRA). Donna is also a past president of the Lions club aiding in programs and medical research for the blind.